To characterize structural changes of HCQ retinopathy with SD-OCT after drug cessation. Setting: Private practice and academic institution. Patient Population: Patients at New England Eye Center and Ophthalmic Consultants of Boston in Boston, MA diagnosed with HCQ retinopathy and followed after drug cessation. Plaquenil maculopathy dose Hydroxychloroquine dosage rheumatoid arthritis Why would a hiv patient use plaquenil There is no single best test for detecting hydroxychloroquine toxicity. However, SD-OCT and VF are good screening tests, and FAF and mfERG can help confirm a diagnosis of suspected retinal toxicity from hydroxychloroquine. Early detection of toxicity is critical to prevent permanent visual loss. 1. Jorge A, Ung C, Young L, Melles RB, Choi HK. Plaquenil Toxicity - Bulls Eye Maculopathy 575 views 70-year-old woman with systemic Lupus erythematosus and clotting problems. She was on the Plaquenil for about eight years and then off the Plaquenil for the last eight years because she developed macular toxicity. Patients with renal or hepatic dysfunction are at an increased risk of toxicity. 1 Other risk factors for retinal toxicity include short stature, obesity, advanced age and/or a pre-existing macular pathology. 1 So, what does this mean for our patient? Are the retinal changes a result of Plaquenil use? Main Outcome Measures: SD-OCT findings suggestive of HCQ retinopathy before parafoveal ellipsoid disruption. Retrospective clinical data review by the Boston Image Reading Center. Plaquenil toxicity oct images Plaquenil Toxicity - OCTMD, Plaquenil Toxicity - Bulls Eye Maculopathy - Retina Gallery. Lichen planopilaris plaquenilRheumatoid arthritis guidelines hydroxychloroquinePlaquenil sun allergyHydroxychloroquine dile Nov 01, 2015 Hydroxychloroquine Maculopathy An Update on Screening and Diagnosis A brief guide for imaging SHIRI SHULMAN, MD. H ydroxychloroquine HCQ; Plaquenil, Sanofi, Bridgewater, NJ is an antimalarial agent that is also commonly used as a treatment for a variety of rheumatologic and dermatologic conditions, such as rheumatoid arthritis and systemic lupus erythematosus. Retinal Physician - Hydroxychloroquine Maculopathy An Update.. Pause the Plaquenil?. Time Domain OCT in Hydroxychloroquine Plaquenil Toxicity.. Of patients with normal hsUHR-OCT images. Following pupillary dilation with 1% tropicamide, hsUHR-OCT imaging was performed using a linear scan protocol with 8192 A-scans per image as previously described.7 All of the hsUHR-OCT images patients and controls were evaluated by 2 observers E. R. and J. S. D. who are retinal spe- Although hydroxychloroquine retinal toxicity is thought to be rare, recent studies suggest it may have a higher prevalence than previously recognized. A large study examining patients with more than 5 years of HCQ use were evaluated with 10-2 visual fields or spectral-domain optical coherence tomography SD OCT. This article is from June 2011 and may contain outdated material. Download PDF. Many systemic medications may cause retinal toxicity. One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine Plaquenil, a chloroquine derivative.